Ibio Inc (IBIO)

0.2645
-0.0155(-5.54%)
  • Volume:
    326,330
  • Bid/Ask:
    0.5000/0.0000
  • Day's Range:
    0.2522 - 0.2956

IBIO Overview

Prev. Close
0.28
Day's Range
0.2522-0.2956
Revenue
2.81M
Open
0.2956
52 wk Range
0.223-1.755
EPS
-0.15
Volume
326,330
Market Cap
52.38M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
223,496
P/E Ratio
-
Beta
-4.52
1-Year Change
-82.25%
Shares Outstanding
218,165,624
Next Earnings Date
Oct 18, 2022
What is your sentiment on Ibio?
or
Market is currently closed. Voting is open during market hours.

Ibio Inc News

  • IBio readies stock offering; shares down 5%
    • BySeeking Alpha-

    Nano cap iBio (IBIO -4.5%) has filed a preliminary prospectus for a public offering of common stock. Price, volume and terms have yet to be announced.Now read: Ritter Pharma...

  • Premarket Gainers as of 9:05 am
    • BySeeking Alpha-

    TRXC +78% FDA's 510(k) clearance for its Senhance System. RCON +26% on signing a three-year strategic cooperation agreement with Beijing OriginWater Purification Engineering...

Ibio Inc Analysis

Ibio Inc Company Profile

Ibio Inc Company Profile

Employees
62

iBio, Inc. is a developer of biopharmaceuticals and FastPharming Manufacturing System. The Company is applying its technologies to develop product candidates to treat or prevent fibrotic diseases, cancers, and infectious diseases. The Company is using its FastPharming Manufacturing System (FastPharming System) and Glycaneering Services to build a portfolio of biologic drug candidates. The Company is also using the FastPharming System to create proteins for others by contract through the Company’s catalog. The Company operates through two segments: Biopharmaceuticals and Bioprocessing. Its Biopharmaceuticals segment, which includes development and licensing in two business units: therapeutics and vaccines. Its Bioprocessing, which includes services and products for research and further manufacturing uses, collectively known as Research & Bioprocess products (RBP). Its pipeline includes IBIO-100, IBIO-101, IBIO-202 and IBIO-400.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesSellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong Sell
SummarySellStrong SellStrong Sell
  • The ego of this CEO has done so much damage. Why not seek a professional for mental disease Tom?
    0
    • ibio will succeed after the CEO is put in jail.
      0
      • hold, well, maybe bouncing to .70. I will hold no other option here. My buddy holds from 2.4 - that is pretty paintful
        0
        • Ibio upgraded by Zacks to hold for no apparent reason.I'm on the fence about selling before year end to offeset capital gains tax but guess I'll hold into next year, see what happens.
          0
          • what you end up doing?
            0
        • Found out ibio wants to do a reverse split. Run for the hills. Worst thing a stock can do. Watch your shares disappear.
          0
          • This is the time to buy ibio. Ray hope your watching.
            0
            • Maybe ibio's vax will work. Lord knows the other ones don't. I know two vaxed ppl that got covid this week. I had to go get tested because I was exposed to them. Moderators, do you approve this message?
              1
              • This 'IBIO' could be de-listed very soon. No hope to rise again. 😢😥
                4
                • This 'IBIO' could be de-listed very soon. No hope to rise again. 😢😥
                  2
                  • I just hope this bag of **** I'm holding turns to gold one day. Hey, a man can dream, right?
                    1